Global Journal of Science Frontier Research, G: Bio-Tech & Genetics, Volume 22 Issue 2

160. Braig, D. et al. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas. Int J Cancer 145, 1148-1161, doi: 10.1002/ijc.32216 (2019). 161. Przybyl, J. et al. Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma. PLoS One 17, e0262272, doi: 10.1371/journal.pone. 0262272 (2022). 162. Akolkar, D. et al. Evaluation of patient-specific cell free DNA assays for monitoring of minimal residual disease in solid tumors. medRxiv , 2022.2004. 2007.22273446, doi: 10.1101/2022.04.07.22273446 (2022). 163. (https://ClinicalTrials.gov/show/NCT02889978) . 164. Liu, M. C. et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol 31, 745-759, doi: 10.1016/j.annonc.2020.02.011 (2020). 165. Keung, E. Z. & Somaiah, N. Overview of liposarcomas and their genomic landscape. Journal of Translational Genetics and Genomics 3, 8, doi: 10.20517/jtgg.2019.03 (2019). 166. Hanahan, D. Hallmarks of Cancer: New Dimensions. Cancer Discov 12, 31-46, doi: 10.1158/ 2159-8290.CD- 21-1059 (2022). 1 Year 2022 33 © 2022 Global Journals Global Journal of Science Frontier Research Volume XXII Issue ersion I VII ( G ) The Genomics of Liposarcoma: A Review and Commentary